Leukotriene receptor antagonists in asthma therapy

In persons with asthma, the cysteinyl leukotrienes possess multiple inflammatory properties in vitro and have long been considered to be a potentially important mediator of asthma and an attractive target for therapeutic intervention. Controlled clinical trials have documented the efficacy of leukot...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of allergy and clinical immunology 2003-01, Vol.111 (1), p.S62-S70
1. Verfasser:	Peters, Stephen P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Asthmatic Agents - therapeutic use Asthma Asthma - diagnosis Asthma - drug therapy Asthma - physiopathology asthma symptoms Biomarkers Clinical trials distal airways Drug dosages dyspnea Dyspnea - complications end points Endpoint Determination Humans Leukotriene Antagonists - therapeutic use Leukotriene D4 - pharmacology Leukotriene receptor antagonists Lung - drug effects Lung - physiopathology Nitric oxide pulmonary function Respiratory Function Tests Smooth muscle
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!